11-26441908-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_031418.4(ANO3):c.47-10G>C variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000689 in 1,602,040 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00056 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00070 ( 1 hom. )
Consequence
ANO3
NM_031418.4 splice_polypyrimidine_tract, intron
NM_031418.4 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.0001735
2
Clinical Significance
Conservation
PhyloP100: 1.37
Genes affected
ANO3 (HGNC:14004): (anoctamin 3) The protein encoded by this gene belongs to the TMEM16 family of predicted membrane proteins, that are also known as anoctamins. While little is known about the function of this gene, mutations in this gene have been associated with some cases of autosomal dominant craniocervical dystonia. Cells from individuals with a mutation in this gene exhibited abnormalities in endoplasmic reticulum-dependent calcium signaling. Studies in rat show that the rat ortholog of this protein interacts with, and modulates the activity of a sodium-activated potassium channel. Deletion of this gene caused increased pain sensitivity in the rat model system. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 11-26441908-G-C is Benign according to our data. Variant chr11-26441908-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 526228.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr11-26441908-G-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000559 (85/152106) while in subpopulation AMR AF= 0.00105 (16/15276). AF 95% confidence interval is 0.000657. There are 0 homozygotes in gnomad4. There are 42 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 85 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANO3 | NM_031418.4 | c.47-10G>C | splice_polypyrimidine_tract_variant, intron_variant | ENST00000256737.8 | |||
ANO3 | NM_001313726.2 | c.230-10G>C | splice_polypyrimidine_tract_variant, intron_variant | ||||
ANO3 | XM_047427399.1 | c.47-10G>C | splice_polypyrimidine_tract_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANO3 | ENST00000256737.8 | c.47-10G>C | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_031418.4 | P3 | |||
ANO3 | ENST00000525139.5 | c.-2-10G>C | splice_polypyrimidine_tract_variant, intron_variant | 5 | |||||
ANO3 | ENST00000531646.1 | c.47-10G>C | splice_polypyrimidine_tract_variant, intron_variant | 4 | |||||
ANO3 | ENST00000672621.1 | c.230-10G>C | splice_polypyrimidine_tract_variant, intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000559 AC: 85AN: 151986Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
85
AN:
151986
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000457 AC: 111AN: 243102Hom.: 0 AF XY: 0.000419 AC XY: 55AN XY: 131342
GnomAD3 exomes
AF:
AC:
111
AN:
243102
Hom.:
AF XY:
AC XY:
55
AN XY:
131342
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000703 AC: 1019AN: 1449934Hom.: 1 Cov.: 29 AF XY: 0.000674 AC XY: 486AN XY: 721338
GnomAD4 exome
AF:
AC:
1019
AN:
1449934
Hom.:
Cov.:
29
AF XY:
AC XY:
486
AN XY:
721338
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000559 AC: 85AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.000565 AC XY: 42AN XY: 74342
GnomAD4 genome
AF:
AC:
85
AN:
152106
Hom.:
Cov.:
32
AF XY:
AC XY:
42
AN XY:
74342
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Dystonic disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at